Special Issue "Recent Advances in Metallo-Drugs"
Deadline for manuscript submissions: 31 March 2024 | Viewed by 3401
Interests: dendrimer chemistry; organic and organophosphorus chemistry; macromolecules for catalysis; nanomedicine and materials
Special Issues, Collections and Topics in MDPI journals
Special Issue in Journal of Personalized Medicine: Personalized and Precision Medicine 2022
Special Issue in Molecules: Women in Nanochemistry
Special Issue in Pharmaceutics: Dendrimers: A Themed Issue in Honor of Professor Donald A. Tomalia on the Occasion of His 85th Birthday for His Outstanding Achievements in Advancing the Field of Dendrimers
Special Issue in Cancers: Selected Papers from International Conference on Nanomedicine and Nanobiotechnology—ICONAN2024
Special Issue in International Journal of Molecular Sciences: Design, Synthesis and Applications of Dendrimer Materials
Since the discovery of the anticancer properties of cisplatin (cis-diamminedichloroplatinum (II)) in 1965 and its approval for clinical use in 1978, the investigation of metal complexes as anticancer chemotherapeutic agents has blossomed. Administration of platinum-based drugs has substantial adverse side effects (e.g., neurotoxicity) and is unable to prevent cancer relapse, and intrinsic or acquired resistance can develop in several types of cancer. Thus, many efforts have been made to develop metallo-drugs based on other metals, such as palladium, gold, ruthenium, copper, or osmium. Different types of ligands have also been developed, as well as vehicles to transport the metallo-drug to its targets. Furthermore, in addition to their anticancer properties, metallo-drugs are usable in other fields, for instance, as antibacterial agents.
The Special Issue of Molecules titled “Recent Advances in Metallo-Drugs” welcomes papers related to recent discoveries involving metal complexes in biology/medicine, particularly (but not only) as anticancer agents.
Prof. Dr. Anne-Marie Caminade
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- biological properties
- transition metals
- noble metals